Cysteinyl 1 Receptor Antagonist Montelukast, Does Not Prevent Peritoneal Membrane Damage in Experimental Chronic Peritoneal Dialysis Model in Rats

Cysteinyl 1 Receptor Antagonist Montelukast, Does Not Prevent Peritoneal Membrane Damage in Experimental Chronic Peritoneal Dialysis Model in Rats

Background/Aims: Continuous ambulatory peritoneal dialysis (CAPD) induces structural changes in the peritoneal membrane such as fibrosis, vasculopathy and angioneogenesis with a reduction in ultrafiltration capacity. Leukotriene (LT) receptor antagonists have been found to be effective to prevent fi...

Full description

Bibliographic Details
Main Authors: Sibel Koçak Yucel, Hakki Arikan, Halil Tugtepe, Fulya Cakalagaoglu, Serhan Tuglular, Emel Akoglu, Cetin Ozener
Format: Article
Language:English
Published: Karger Publishers 2014-12-01
Series:Kidney & Blood Pressure Research
Subjects:
Peritoneal dialysis
Cytokines
Montelukast
Peritoneal membrane
Online Access:http://www.karger.com/Article/FullText/368477

Internet

http://www.karger.com/Article/FullText/368477

Similar Items